Preventing effects of a novel anti-parkinsonian agent zonisamide on dopamine quinone formation

scientific article published on 10 October 2007

Preventing effects of a novel anti-parkinsonian agent zonisamide on dopamine quinone formation is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.NEURES.2007.10.002
P8608Fatcat IDrelease_rkwngpyxdrhnvjeogrqzbmuso4
P698PubMed publication ID18022268

P50authorFrancisco J Diaz-CorralesQ43253747
P2093author name stringNorio Ogawa
Miho Murata
Ikuko Miyazaki
Ko Miyoshi
Masato Asanuma
P433issue1
P921main subjectParkinson's diseaseQ11085
P304page(s)106-113
P577publication date2007-10-10
P1433published inNeuroscience ResearchQ15764280
P1476titlePreventing effects of a novel anti-parkinsonian agent zonisamide on dopamine quinone formation
P478volume60

Reverse relations

cites work (P2860)
Q46130675A novel anti-Parkinsonian agent, zonisamide, attenuates MPTP-induced neurotoxicity in mice
Q64779011Dopamine Transporter Imaging in Parkinson Disease: Progressive Changes and Therapeutic Modification after Anti-parkinsonian Medications
Q50266408Efficacy of zonisamide in a case of Parkinson's disease with intractable resting and re-emergent tremor
Q35092165Medical management of Parkinson's disease: focus on neuroprotection
Q37863681Motor complications, levodopa metabolism and progression of Parkinson's disease
Q38684428Neuroprotection as a Potential Therapeutic Perspective in Neurodegenerative Diseases: Focus on Antiepileptic Drugs
Q39076196Protective effects of zonisamide against rotenone-induced neurotoxicity
Q49016618Quinoprotein adducts accumulate in the substantia nigra of aged rats and correlate with dopamine-induced toxicity in SH-SY5Y cells
Q33615756The antiepileptic drug zonisamide inhibits MAO-B and attenuates MPTP toxicity in mice: clinical relevance
Q42854732Therapeutic effect of a novel anti-parkinsonian agent zonisamide against MPTP (1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine) neurotoxicity in mice
Q43083221Therapeutic effect of a novel anti-parkinsonian agent zonisamide against MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in mice
Q37352050What's in the pipeline for the treatment of Parkinson's disease?
Q37356891Zonisamide: a review of the clinical and experimental evidence for its use in Parkinson's disease
Q45931490Zonisamide: in Parkinson's disease.

Search more.